Back to Search Start Over

RNA methylation and cancer treatment.

Authors :
Yang, Baochen
Wang, Jing-Quan
Tan, Yao
Yuan, Runzhu
Chen, Zhe-Sheng
Zou, Chang
Source :
Pharmacological Research. Dec2021, Vol. 174, pN.PAG-N.PAG. 1p.
Publication Year :
2021

Abstract

To this date, over 100 different types of RNA modification have been identified. Methylation of different RNA species has emerged as a critical regulator of transcript expression. RNA methylation and its related downstream signaling pathways are involved in plethora biological processes, including cell differentiation, sex determination and stress response, and others. It is catalyzed by the RNA methyltransferases, is demethylated by the demethylases (FTO and ALKBH5) and read by methylation binding protein (YTHDF1 and IGF2BP1). Increasing evidence indicates that this process closely connected to cancer cell proliferation, cellular stress, metastasis, immune response. And RNA methylation related protein has been becoming a promising targets of cancer therapy. This review outlines the relationship between different types of RNA methylation and cancer, and some FTO inhibitors in cancer treatment. [Display omitted] [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
10436618
Volume :
174
Database :
Academic Search Index
Journal :
Pharmacological Research
Publication Type :
Academic Journal
Accession number :
153928207
Full Text :
https://doi.org/10.1016/j.phrs.2021.105937